Phagelux In-licenses Delivery Systems for Phage-based Products

Phagelux, Inc., a Shanghai company that is developing phage-based anti-bacterial products, has in-licensed several biodegradable polymer delivery systems from Iveria Technologies of the US.  Mark Engel, Chairman of Phagelux, told ChinaBio® Today, " The technologies acquired will primarily be used for human health although there are also some potential applications in animal health area, especially pets ." Phages are  potential alternatives to many uses of antibiotics, including drug-resistant bacteria strains. Engel said the Iveria deal contained provisions for upfront payments, milestones and royalties on sales. More details.... Share this with colleagues: // //